Intrinsic Value of S&P & Nasdaq Contact Us

Atai Beckley N.V ATAI NASDAQ

NASDAQ Global Market • Healthcare • Medical - Pharmaceuticals • NL • USD

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.75
+193.8%

Atai Beckley N.V (ATAI) is a publicly traded company in the Healthcare sector, operating within the Medical - Pharmaceuticals industry. The company is headquartered in Amstelveen, Netherlands. The current CEO is Srinivas G. Rao.

ATAI has IPO date of 2021-06-18, 54 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $754.5M.

About Atai Beckley N.V

Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.

📍 Prof. J.H. Bavincklaan 7, Amstelveen 1183 AT 📞 31 20 793 2536
Company Details
SectorHealthcare
IndustryMedical - Pharmaceuticals
CountryNetherlands
ExchangeNASDAQ Global Market
CurrencyUSD
IPO Date2021-06-18
CEOSrinivas G. Rao
Employees54
Trading Info
Current Price$4.00
Market Cap$754.5M
52-Week Range1.15-6.75
Beta1.57
ETFNo
ADRNo
CUSIPN0731H103
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message